7210 Research and experimental development on natural sciences and engineering

Developer and manufacturer of bioabsorbable polymeric scaffolds, films, and related instrumentations.

Develops biological products for use in various surgical procedures.

A biopharmaceutical company, engages in the development and commercialization of treatments for diseases of the inner and middle ear.

Developing the GridION system, a new generation of technology that uses nanopores - very small holes created in electrically resistant membranes.

Bringing technology to the drugs of abuse testing market.

The development and validation of a logical model of P53 for cancer care clinical management.

Developer of the CLARISONIC™ Skin Care System.

Provider of an integrated platform for genetic analysis.

Develops peptide, peptide mimetic and small molecule agonists with a focus on melanocortin and natriuretic peptide receptor systems

An antibody development company with focus in inflammation/oncolgy.

Develops novel cell-based assays and tools to enable multiplexed measurements of molecular events in a quantitative and scalable manner

A start-up biotech specializing in antibiotic target validation and drug discovery.

A privately-held medical device company, engaged in the development of spinal implants for the spine and orthopedic markets

Provider of single-cell sequencing solutions.

Pasteuria Bioscience is addressing agriculture's largest unsolved pest problem: plant-parasitic nematodes.

Provider of comprehensive anatomic, clinical and molecular pathology services.

A full-service biomarker assay development and commercialization company that uniquely combines expertise in clinical biomarker diagnostics with acces

Direct-to-consumer genetic diagnostic service.

Developing unique dual and triple combination products for the treatment of widely prevalent respiratory diseases

Bioimplants company for soft tissue repair and wound care for diabetic ulcers.

Biopharmaceutical company engaged in the development of novel autoimmune, inflammatory, and viral therapies.

Human genome interpretation company.

A biotechnology company developing novel therapeutics to promote vascular repair.

Develops fully human therapeutic monoclonal antibody (mAb)

A pharmaceutical company, develops and commercializes small molecule drugs for treating pain and neurological conditions.

Rockville-based biotechnology company.

Develops novel cancer drugs.

Initially, Pharmion concentrated its efforts on licensing products in the areas of hematology, oncology and supportive care.

Develops novel approaches to the delivery of siRNA and other macromolecules

A therapeutic drug development company developing treatments for multiply resistant bacteria.

Formed to develop light sensitive drugs for indications including oncology and infection.

Biotechnology company focused on tissue protection and oncology.

Biotechnology company specializing in the genomics and proteomics fields.

Biopharmaceutical company with a broad portfolio of novel compounds for chronic diseases.

Biopharmaceutical company.

Biotechnology company seeking to become the leader in therapeutic vaccines, focused initially on the treatment of cancer

Oncology Therapeutics. Acquired by Roche in April 2008.

A pioneering biotechnology company that specialises in the differentiation of stem cells to obtain cell types for a range of biomedical applications.

PointCare Technologies, Inc. is a fully integrated, privately held, ISO-certified medical diagnostics company.

Biotech company that aim to solve structures of G protein-coupled receptors (GPCRs).

Applies precision chemistry to develop protein and peptide-based drugs.

Develops and commercializes oncology products.

Population Genetics Technologies (PGT) Ltd is creating new paradigms for performing large-scale population genetics studies.

An early stage biotechnology company

Provider of outsourced clinical trial services across all phases of pharmaceutical and biotech drug development in the United States.

Biotechnology company providing a cancer diagnostics reference laboratory, delivering the latest in advanced diagnostics and personalized medicine.

Develops and distributes biopharmaceutical products for chronic diseases, using molecular engineering and protein manufacturing technologies.

Provider of cancer drugs that uniquely target physiological attributes of solid tumors.

Investigating a novel approach to counter antibiotic resistance and defeat infectious diseases using a DNA decoy technique.

Innovative clinical stage vaccine company.

Develops stem cell technologies to discover drugs that regenerate tissues of the human body.

Developing a novel cartiledge replacement therapy that has the potential to revolutionise the treatment of acute knee injuries.

Based on Dstl's proprietary ultrasound technology for manipulating particles.

A biotechnology company developing novel biologic therapeutics to treat fibroproliferative diseases.

Stem cell therapy company

Biopharmaceutical company.

Discovers, researches, and develops compounds to treat cachexia focusing on muscle-wasting associated with cancer.

A biotechnology company developing a novel class of biopharmaceuticals based on glycan-binding decoy proteins.

Biotechnology company dedicated to the discovery of novel peptide and small molecule compounds.

Cardiac diagnostic devices